Gene therapy approval may be rocky road for industry.
Gavaghan
H
H
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy*; D026683:Advisory Committees; D002985:Clinical Protocols; D002986:Clinical Trials as Topic; D017322:Clinical Trials, Phase II as Topic; D026724:Ethical Review; D035082:Federal Government; D015316:Genetic Therapy / Q000592:standards; D033161:Government Regulation; D006801:Humans; D009316:National Institutes of Health (U.S.); D014481:United States